DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
High-throughput screening technologies have provided a large amount of drug sensitivity data for a panel of cancer cell lines and hundreds of compounds. Computational approaches to analyzing these data can benefit anticancer therapeutics by identifying molecular genomic determinants of drug sensitivity and developing new anticancer drugs. In this study, we have developed a deep learning architecture to improve the performance of drug sensitivity prediction based on these data. We integrated both genomic features of cell lines and chemical information of compounds to predict the half maximal inhibitory concentrations [Formula: see text] on the Cancer Cell Line Encyclopedia (CCLE) and the Genomics of Drug Sensitivity in Cancer (GDSC) datasets using a deep neural network, which we called DeepDSC. Specifically, we first applied a stacked deep autoencoder to extract genomic features of cell lines from gene expression data, and then combined the compounds' chemical features to these genomic features to produce final response data. We conducted 10-fold cross-validation to demonstrate the performance of our deep model in terms of root-mean-square error (RMSE) and coefficient of determination [Formula: see text]. We show that our model outperforms the previous approaches with RMSE of 0.23 and [Formula: see text] of 0.78 on CCLE dataset, and RMSE of 0.52 and [Formula: see text] of 0.78 on GDSC dataset, respectively. Moreover, to demonstrate the prediction ability of our models on novel cell lines or novel compounds, we left cell lines originating from the same tissue and each compound out as the test sets, respectively, and the rest as training sets. The performance was comparable to other methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep Residual Learning for Image Recognition
He, K., Zhang, X., Ren, S., & Sun, J. (2016) · 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2016.90 · Cited by 235,474
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
Adam: A Method for Stochastic Optimization
Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Approximation by superpositions of a sigmoidal function
Cybenko, G. (1989) · Mathematics of Control, Signals, and Systems · doi:10.1007/bf02551274 · Cited by 13,883
Hinton, G., Deng, L., Yu, D., Dahl, G., Mohamed, A.-R., Jaitly, N., Senior, A., Vanhoucke, V., Nguyen, P., Sainath, T., et al. (2012) · IEEE Signal Processing Magazine · doi:10.1109/msp.2012.2205597 · Cited by 10,260 · cited 1×
“Particularly, deep learning has achieved remarkable success in computer vision [25], [26], speech recognition [27], [28], natural language processing [29], [30] and bioinformatics [31], [32], [33] in recent years.”
Speech recognition with deep recurrent neural networks
Graves, A., Mohamed, A.-R., & Hinton, G. (2013) · 2013 IEEE International Conference on Acoustics, Speech and Signal Processing · doi:10.1109/icassp.2013.6638947 · Cited by 8,893 · cited 1×
“Particularly, deep learning has achieved remarkable success in computer vision [25], [26], speech recognition [27], [28], natural language processing [29], [30] and bioinformatics [31], [32], [33] in recent years.”
BackgroundThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · cited 1×
“The Cancer Cell Line Encyclopedia (CCLE) project compiled genomic profiles of 947 human cancer cell lines, and pharmacologic profiles of 24 anticancer drugs across 479 cancer cell lines to benefit personalized medicine [5].”
BackgroundFast and Accurate Deep Network Learning by Exponential Linear Units (ELUs)
Clevert, D.-A., Unterthiner, T., & Hochreiter, S. (2015) · arXiv · doi:10.48550/arxiv.1511.07289 · Cited by 4,513 · cited 1×
“Except for the input layer and output layer, the rest hidden layers have 1,000, 800, 500, and 100 neural units, and all these four layers share the same activation function elu [46].”
BackgroundGolbraikh, A., & Tropsha, A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00123-1 · Cited by 3,735 · cited 1×
“We also choose coefficient of determination R 2 [50] described in (6) to measure the predictive performance of our deep learning models. where N is the size of the test data, y i and ~ y i are the target drug sensitivity data and the predicted counterpart of i th input data, and (cid:2) y is the…”
MethodSystematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456 · cited 1×
“The Genomics of Drug Sensitivity in Cancer (GDSC) is another effort to catalogue genomic profiles of 639 human cancer cell lines and their drug response data to 130 drugs aiming to identify genomic biomarkers of drug sensitivity in cancer cells [6].”
BackgroundSelf-Normalizing Neural Networks
Klambauer, G., Unterthiner, T., Mayr, A., & Hochreiter, S. (2017) · arXiv · doi:10.48550/arxiv.1706.02515 · Cited by 2,267
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164 · cited 1×
“…methods known as Quantitative Structure-Activity Relation-ship (QSAR) generally build models on a set of fixed cell lines or tissues using drug properties under the assumption that chemically and structurally similar compounds may have similar biological effect on known cell lines [12], [13], [14].”
MethodMapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789 · cited 1×
“Previous studies on these datasets are wide-ranging, such as novel anticancer drug discovery [1], [7], human cancer pathogenesis analysis [8], [9], anticancer drug repositioning [10], [11], and so on.”
BackgroundInconsistency in large pharmacogenomic studies
Haibe-Kains, B., El-Hachem, N., Birkbak, N. J., Jin, A. C., Beck, A. H., Aerts, H. J. W. L., & Quackenbush, J. (2013) · Nature · doi:10.1038/nature12831 · Cited by 499 · cited 2×
“Although the prediction errors of DeepDSC are smaller than the previous studies in the area, it does have the limitation of training on a merged dataset for the data inconsistency among GDSC, CCLE and high-throughput screening datasets [41].”
MethodGillet, J.-P., Calcagno, A. M., Varma, S., Marino, M., Green, L. J., Vora, M. I., Patel, C., Orina, J. N., Eliseeva, T. A., Singal, V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111840108 · Cited by 477 · cited 1×
“CULTURED Cancer cell lines with heterogeneous genomic backgrounds and gene expressions are fundamental materials to study the molecular basis of drug activity [1] and to discover novel anticancer drugs in cancer biology, despite their genomic differences from original tissue or tumor samples [2], [3].”
BackgroundCancer Cell Lines for Drug Discovery and Development
Wilding, J. L., & Bodmer, W. F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2971 · Cited by 432 · cited 1×
“Previous studies on these datasets are wide-ranging, such as novel anticancer drug discovery [1], [7], human cancer pathogenesis analysis [8], [9], anticancer drug repositioning [10], [11], and so on.”
Background
Cited by
Using machine learning approaches for multi-omics data analysis: A review
Reel, P. S., Reel, S., Pearson, E., Trucco, E., & Jefferson, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107739 · Cited by 903
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Artificial intelligence in radiotherapy
Li, G., Wu, X., & Ma, X. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.005 · Cited by 46
Xie, Y., Peng, J., & Zhou, Y. (2019) · doi:10.21203/rs.2.18936/v1 · Cited by 5
Learning chemical sensitivity reveals mechanisms of cellular response
Connell, W., Garcia, K., Goodarzi, H., & Keiser, M. J. (2024) · Communications Biology · doi:10.1038/s42003-024-06865-4 · Cited by 4
Metadata
- Authors
- Li, M., Wang, Y., Zheng, R., Shi, X., Li, Y., Wu, F.-X., & Wang, J.
- Venue
- IEEE/ACM Transactions on Computational Biology and Bioinformatics
- Published
- 2021-03-01
- Volume
- 18
- Issue
- 2
- Pages
- 575-582
- ISSN
- 1545-5963 (ISSN-L)
- 1557-9964
- 2374-0043
- OpenAlex
- W2946834067
- Cited by
- 160
- References
- 17
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.